PUNE, India, May 24, 2017 /PRNewswire/ --
RnRMarketResearch.com adds "Bone Metastasis - Pipeline Review, H1 2017"therapeutic market research report of 100 pages with latest updates, data and information to its online business intelligence library.
The report "Bone Metastasis - Pipeline Review, H1 2017" provides comprehensive information
Bone metastasis occurs when cancer cells spread from their original site to a bone. Signs and symptoms of bone metastasis include bone pain, broken bones, urinary incontinence, bowel incontinence and weakness in the legs. The predisposing factors include certain kinds of cancer (breast, prostate, lung, thyroid, and kidney cancers). Treatment options for bone metastasis are chemotherapy, surgery and radiation therapy.
Complete report is available @ http://www.rnrmarketresearch.com/bone-metastasis-pipeline-review-h1-2017-market-report.html
Bone Metastasis (Oncology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Directs proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.
Companies discussed in this report include Ablynx NV, Amgen Inc, Amura Holdings Ltd, BiologicsMD Inc, ChemoCentryx Inc, Deciphera Pharmaceuticals LLC, Eli Lilly and Company, Leadiant Biosciences Inc, Lupin Ltd, Mirati Therapeutics Inc, Oncobiologics Inc, Oncodrone BV, OPKO Health Inc, Osteologix Holdings Plc, R Pharm, Redx Pharma Plc, Taiho Pharmaceutical Co Ltd, Terpenoid Therapeutics Inc
Order a Purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=1010178 . (This report is available at upto 25% Discount till June 02nd 2017.)
Drugs profile discussed in this report include ADM-01, ALX-0141, AM-3701, AMG-161, BKM-1644, BKM-1740, BMD-3151, calcifediol ER, CCX-354, DCC-3014, denosumab, denosumab biosimilar, emibetuzumab, LG-1980, NBS-101, OCD-155, roneparstat, RPH-203, RSF-102, RSF-103, sitravatinib, TAS-115, TPH-9, vicrostatin
Explore more reports of Therapeutics Market Research at http://www.rnrmarketresearch.com/reports/life-sciences/pharmaceuticals/therapeutics
Related reports on "Bone Metastasis Global Clinical Trials Review H2 2016":
Bone Metastasis Global Clinical Trials Review, H2, 2016
"Bone Metastasis Global Clinical Trials Review H2, 2016" provides an overview of Bone Metastasis clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Metastasis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Clinical Trial Reports are generated using proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process..
RnRMarketResearch.com is your one stop market research and industry analysis reports' library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage. Category focused research, country reports, company profiles, regional and global industry profiles and guides to premium reports offering extensive coverage of other 20+ industries are all available in our library of syndicated market research reports.
Contact: Ritesh Tiwari 2nd Floor, Metropole Bund Garden Road Pune - 411001 India. Tel: + 1-888-391-5441 E-mail: firstname.lastname@example.org
Subscribe to our Free Newsletters!
Cachexia refers to severe muscle and fat loss, anorexia and marked weight loss due to an underlying ...
Exotropia or outward eye deviation is a form of squint. Proper evaluation and timely intervention ...
Glaucoma is a group of disorders involving the optic nerve, often associated with a rise in ...View All